In terms of US tax liability PAC will need to pay approximately $AUD57.68M based on a 28% long term capital gains tax rate - 21% federal tax and 7% Washington State Capital Gains tax is due.
The cash to be received after tax is $AUD199.62M.
This assumes all of the losses in note 4 of the financials can be used ($AUD46.3M).
Calculation in AUD as follows:
$257.3M GQG sale proceeds
less $46.3M in tax losses
less $5M investment amount
$206M net proceeds after applying tax losses
*28% in taxes (21% Federal + 7% Washington State)
$57.68M ($206M x 28%)
Net proceeds $257.3M - $57.68M = $199.62M
If GQG was held by an Australian entity it could have used the long term holding 50% discount. Assuming net sale proceeds would be:
$257.3M GQG sale proceed
less $46.3M in tax losses
less $5M investment amount
Divide by 2 (50% discount)
$103M in taxable gains
*30% (because over $50M in revenue)
$30.9M ($103M x 30%)
Net proceeds $257.3M - $30.9M = $226.4M
Happy to be corrected on above calculations if anyone has a bit more insight into US taxes.
- Forums
- ASX - By Stock
- PAC selling GQG shares - AFR Street Talk
In terms of US tax liability PAC will need to pay approximately...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$10.92 |
Change
0.000(0.00%) |
Mkt cap ! $569.9M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 192 | $10.73 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.91 | 411 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 192 | 10.730 |
3 | 792 | 10.720 |
1 | 397 | 10.420 |
1 | 2500 | 10.410 |
2 | 1750 | 10.400 |
Price($) | Vol. | No. |
---|---|---|
10.910 | 411 | 8 |
10.920 | 535 | 4 |
10.930 | 66 | 2 |
10.940 | 140 | 1 |
10.980 | 26136 | 2 |
Last trade - 10.42am 03/07/2024 (20 minute delay) ? |
Featured News
PAC (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online